Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement
Abstract
In a previous study, children 18 to 36 months of age and seropositive for respiratory syncytial virus (RSV) were vaccinated with an RSV subunit vaccine (PFP-1) consisting of the viral fusion protein. Vaccines developed substantial increases in anti-fusion and neutralizing antibody and exhibited prot …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
male
Child
Infant
preschool
Clinical Trial
Antibodies
Double-Blind Method
r c welliver
respiratory syncytial virus infections / prevention & control*
time factors
hn protein*
viral envelope proteins
human / immunology*
human / isolation & purification
respiratory syncytial virus
viral / blood*
viral proteins / immunology*
viral vaccines / immunology*
immunoglobulin e / blood
pmid:8036830
doi:10.1016/0264-410x(94)90316-6
d a tristram
p paradiso
immunoglobulin a / blood
Access
Citation
ID:
118196
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
118196
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
